Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'DEFORNI M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 17 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. CHABOT GG; ARMAND JP; TERRET C; DEFORNI M; ABIGERGES D; WINOGRAD B; IGWEMEZIE L; SCHACTER L; KAUL S; ROPERS J; BONNAY M
      ETOPOSIDE BIOAVAILABILITY AFTER ORAL-ADMINISTRATION OF THE PRODRUG ETOPOSIDE PHOSPHATE IN CANCER-PATIENTS DURING A PHASE-I STUDY

      Journal of clinical oncology
    2. WIBAULT P; BENSMAINE MEA; DEFORNI M; ARMAND JP; BERNAL ET; GUILLOT T; RECONDO G; DOMENGE C; JANOT F; BOREL C; LUBOINSKI B; ESCHWEGE F; CVITKOVIC E
      INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL

      Journal of clinical oncology
    3. ARMAND JP; DUCREUX M; MAHJOUBI M; ABIGERGES D; BUGAT R; CHABOT G; HERAIT P; DEFORNI M; ROUGIER P
      CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER

      European journal of cancer
    4. MARTY M; KLEISBAUER JP; FOURNEL P; VERGNENEGRE A; CARLES P; LORIAKANZA Y; SIMONETTA C; DEBRUIJN KM; LAURAINE P; DIDIER A; CUPISSOL D; BERGERAT JP; PUJAZON MC; HERON JF; DRENO B; TAYTARD A; GUERIN JC; CLAVIER J; ROBINET G; BLANCHON F; BALMES P; MUIR JF; PAILLOTIN D; POIRIER R; BONNETERRE J; MELLONI B; ROCHE H; DEPIERRE A; PLAGNE R; SOUQUET PJ; ARMAND JP; DEFORNI M
      IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS

      Anti-cancer drugs
    5. DEFORNI M; CHABOT GG; ARMAND JP; GOUYETTE A; KLINKALAK M; RECONDO G
      PHASE-I AND PHARMACOLOGY STUDY OF FLAVONE ACETIC-ACID ADMINISTERED 2 OR 3 TIMES WEEKLY WITHOUT ALKALINIZATION

      Cancer chemotherapy and pharmacology
    6. LEMAIRE L; MALETMARTINO MC; MARTINO R; DEFORNI M; LASSERRE B
      THE TRIS FORMULATION OF FLUOROURACIL IS MORE CARDIOTOXIC THAN THE SODIUM-SALT FORMULATIONS

      Oncology Reports
    7. CHATELUT E; ROSTAING L; GUALANO V; VISSAC T; DEFORNI M; TONTHAT H; SUC JM; HOUIN G; CANAL P
      PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT SUFFERING FROM ADVANCED OVARIAN-CARCINOMA WITH HEMODIALYSIS-DEPENDENT PENAL INSUFFICIENCY

      Nephron
    8. DEFORNI M; BUGAT R; CHABOT GG; CULINE S; EXTRA JM; GOUYETTE A; MADELAINE I; MARTY ME; MATHIEUBOUE A
      PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS

      Cancer research
    9. LEMAIRE L; ARELLANO M; MALETMARTINO MC; MARTINO R; DEFORNI M
      5-FLUOROURACIL CARDIOTOXICITY - A QUESTIO N OF FORMULATION

      Bulletin du cancer
    10. DEFORNI M; CHABOT GG; ARMAND JP; FONTANA X; RECONDO G; DOMENGE C; CARDE P; BARBU M; GOUYETTE A
      PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS

      European journal of cancer
    11. MULLER C; CHATELUT E; GUALANO V; DEFORNI M; HUGUET F; ATTAL M; CANAL P; LAURENT G
      CELLULAR PHARMACOKINETICS OF DOXORUBICIN IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - COMPARISON OF BOLUS ADMINISTRATION AND CONTINUOUS-INFUSION

      Cancer chemotherapy and pharmacology
    12. CODY R; STEWART D; DEFORNI M; MOORE M; DALLAIRE B; AZARNIA N; GYVES J
      MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER

      American journal of clinical oncology
    13. ARMAND JP; CVITKOVIC E; RECONDO G; WIBAULT P; SCHWAAB G; DOMENGE C; TELLEZBERNAL E; GANDIA D; LUBOINSKI B; ESCHWEGE F; DEFORNI M
      SALVAGE CHEMOTHERAPY IN RECURRENT HEAD AND NECK-CANCER - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE

      American journal of otolaryngology
    14. NGUYEN T; DEFORNI M; ARMAND JP; GUEGUEN M; AVRIL MF
      COMPLETE REMISSION OF A SQUAMOUS-CELL CAR CINOMA TREATED WITH THE ASSOCIATION OF INTERFERON-ALPHA 2A AND ISOTRETINOIN AFTER FAILURE OF CONVENTIONAL THERAPIES

      Annales de dermatologie et de venereologie
    15. BACHAUD JM; DAVID JM; SHUBINSKI RE; PERINEAU D; BOUSSIN G; SERRANO E; DEFORNI M; PESSEY JJ; DALYSCHVEITZER NJ
      PREDICTIVE FACTORS OF A COMPLETE RESPONSE TO AND ADVERSE-EFFECTS OF ACDDP-5FU COMBINATION AS PRIMARY THERAPY FOR HEAD AND NECK SQUAMOUS CARCINOMAS

      Journal of Laryngology and Otology
    16. DEFORNI M; GUALANO V; CANAL P; MARTEL P; IZARSOUM F; CHEVREAU C; SOULIE P; ROCHE H; BUGAT R
      CONTINUOUS-INFUSION OF 5-FLUOROURACIL BY DOUBLE ROUTE (INTRAVENOUS AND INTRAPERITONEAL) WITH MODULATION BY FOLINIC ACID - CLINICAL AND PHARMACOKINETIC, PHASE-I STUDY IN PATIENTS WITH INTRAABDOMINAL MALIGNANCIES

      Bulletin du cancer
    17. DEFORNI M; BONEU A; OTAL P; MARTEL P; SHUBINSKI R; BUGAT R; LUCOT H
      ANATOMIC CHANGES IN THE ABDOMINAL-CAVITY DURING INTRAPERITONEAL CHEMOTHERAPY - PROSPECTIVE-STUDY USING SCINTIGRAPHIC PERITONEOGRAPHY

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 15:20:10